Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (17)

2023

  1. Effectiveness and persistence with selexipag in pulmonary arterial hypertension in the real-life setting

    European Journal of Internal Medicine

2022

  1. Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)

    Scientific Reports

  2. Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registry

    Journal of Internal Medicine, Vol. 292, Núm. 1, pp. 116-126

  3. Pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension: the Spanish experience

    Annals of Cardiothoracic Surgery, Vol. 11, Núm. 2, pp. 151-160

2020

  1. Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: Results from the PRACMA study

    BMC Pulmonary Medicine, Vol. 20, Núm. 1

2019

  1. Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry

    International Journal of Cardiology, Vol. 275, pp. 158-164

2014

  1. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?

    International Journal of Cardiology, Vol. 171, Núm. 1, pp. 15-23

2013

  1. Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure

    European Journal of Heart Failure, Vol. 15, Núm. 8, pp. 877-884

  2. Health-Related Quality of Life in a National Cohort of Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

    Archivos de Bronconeumologia, Vol. 49, Núm. 5, pp. 181-188

  3. National consensus on the diagnosis, risk stratification and treatment of patients with pulmonary embolism

    Archivos de Bronconeumologia, Vol. 49, Núm. 12, pp. 534-547

  4. Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation

    Clinical Transplantation, Vol. 27, Núm. 6

2012

  1. Cost effectiveness of prostacyclins in pulmonary arterial hypertension

    Applied Health Economics and Health Policy, Vol. 10, Núm. 3, pp. 175-188

  2. Survival in pulmonary hypertension in Spain: Insights from the Spanish registry

    European Respiratory Journal, Vol. 40, Núm. 3, pp. 596-603

2011

  1. Registros de enfermedades respiratorias en España: fundamentos y organización

    Archivos de Bronconeumologia, Vol. 47, Núm. 8, pp. 389-396

2009

  1. Reply

    Revista Espanola de Cardiologia

2008

  1. Standards of care in pulmonary hypertension

    Revista Espanola de Cardiologia, Vol. 61, Núm. 2, pp. 170-184

  2. Standards of care in pulmonary hypertension. Consensus statement of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Cardiology (SEC)

    Archivos de Bronconeumologia, Vol. 44, Núm. 2, pp. 87-99